Arginine depletion therapy with ASS1 inhibition [23] could have a role in the treatment of tumors proficient for arginine synthesis (extensive expression of ASS1 by cancer cells), provided that the tumor stroma does not already play this role by ARG2 overexpression. Here, ASS1 is linked to cancer.